These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 35907153

  • 1. Patient Perspective on Acute Hepatic Porphyria with Sporadic Attacks: A Chronic Disease with Substantial Health-Related Quality of Life Impacts.
    Wheeden K, Lyon Howe D, Burrell S, Gill L, Chamberlayne J, Williams ER, Simon A, Ko JJ, Mora J, Wells T, Evans C, Paulich M, Meninger S, Lombardelli S.
    Adv Ther; 2022 Sep; 39(9):4330-4345. PubMed ID: 35907153
    [Abstract] [Full Text] [Related]

  • 2. AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.
    Wang B, Bonkovsky HL, Lim JK, Balwani M.
    Gastroenterology; 2023 Mar; 164(3):484-491. PubMed ID: 36642627
    [Abstract] [Full Text] [Related]

  • 3. Patient and caregiver experiences of living with acute hepatic porphyria in the UK: a mixed-methods study.
    Gill L, Burrell S, Chamberlayne J, Lombardelli S, Mora J, Mason N, Schurer M, Merkel M, Meninger S, Ko JJ.
    Orphanet J Rare Dis; 2021 Apr 26; 16(1):187. PubMed ID: 33902669
    [Abstract] [Full Text] [Related]

  • 4. Patient Perspective on Acute Intermittent Porphyria with Frequent Attacks: A Disease with Intermittent and Chronic Manifestations.
    Simon A, Pompilus F, Querbes W, Wei A, Strzok S, Penz C, Howe DL, Hungate JR, Kim JB, Agarwal S, Marquis P.
    Patient; 2018 Oct 26; 11(5):527-537. PubMed ID: 29915990
    [Abstract] [Full Text] [Related]

  • 5. Clinical features of acute attacks, chronic symptoms, and long-term complications among patients with acute hepatic porphyria in Japan: a real-world claims database study.
    Horie Y, Yasuoka Y, Adachi T.
    Orphanet J Rare Dis; 2023 Dec 08; 18(1):384. PubMed ID: 38066651
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Detecting rare diseases in electronic health records using machine learning and knowledge engineering: Case study of acute hepatic porphyria.
    Cohen AM, Chamberlin S, Deloughery T, Nguyen M, Bedrick S, Meninger S, Ko JJ, Amin JJ, Wei AJ, Hersh W.
    PLoS One; 2020 Dec 08; 15(7):e0235574. PubMed ID: 32614911
    [Abstract] [Full Text] [Related]

  • 9. Experiences and concerns of patients with recurrent attacks of acute hepatic porphyria: A qualitative study.
    Naik H, Stoecker M, Sanderson SC, Balwani M, Desnick RJ.
    Mol Genet Metab; 2016 Nov 08; 119(3):278-283. PubMed ID: 27595545
    [Abstract] [Full Text] [Related]

  • 10. EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks.
    Gouya L, Ventura P, Balwani M, Bissell DM, Rees DC, Stölzel U, Phillips JD, Kauppinen R, Langendonk JG, Desnick RJ, Deybach JC, Bonkovsky HL, Parker C, Naik H, Badminton M, Stein PE, Minder E, Windyga J, Bruha R, Cappellini MD, Sardh E, Harper P, Sandberg S, Aarsand AK, Andersen J, Alegre F, Ivanova A, Talbi N, Chan A, Querbes W, Ko J, Penz C, Liu S, Lin T, Simon A, Anderson KE.
    Hepatology; 2020 May 08; 71(5):1546-1558. PubMed ID: 31512765
    [Abstract] [Full Text] [Related]

  • 11. The clinical importance of early acute hepatic porphyria diagnosis: a national cohort.
    Edel Y, Mamet R, Cohen S, Shepshelovich D, Levi A, Sagy I.
    Intern Emerg Med; 2021 Jan 08; 16(1):133-139. PubMed ID: 32372331
    [Abstract] [Full Text] [Related]

  • 12. Quantifying the impact of symptomatic acute hepatic porphyria on well-being via patient-reported outcomes: Results from the Porphyria Worldwide Patient Experience Research (POWER) study.
    Dickey A, Wheeden K, Lyon D, Burrell S, Hegarty S, Falchetto R, Williams ER, Barman-Aksözen J, DeCongelio M, Bulkley A, Matos JE, Mnif T, Mora J, Ko JJ, Meninger S, Lombardelli S, Nance D.
    JIMD Rep; 2023 Jan 08; 64(1):104-113. PubMed ID: 36636593
    [Abstract] [Full Text] [Related]

  • 13. Estimating the broader fiscal consequences of acute hepatic porphyria (AHP) with recurrent attacks in Belgium using a public economic analytic framework.
    Connolly MP, Kotsopoulos N, Vermeersch S, Patris J, Cassiman D.
    Orphanet J Rare Dis; 2021 Aug 04; 16(1):346. PubMed ID: 34348763
    [Abstract] [Full Text] [Related]

  • 14. RNAi therapy with givosiran significantly reduces attack rates in acute intermittent porphyria.
    Sardh E, Harper P.
    J Intern Med; 2022 May 04; 291(5):593-610. PubMed ID: 35067977
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Biochemical Diagnosis of Acute Hepatic Porphyria: Updated Expert Recommendations for Primary Care Physicians.
    Anderson KE, Lobo R, Salazar D, Schloetter M, Spitzer G, White AL, Young RM, Bonkovsky HL, Frank EL, Mora J, Tortorelli S.
    Am J Med Sci; 2021 Aug 04; 362(2):113-121. PubMed ID: 33865828
    [Abstract] [Full Text] [Related]

  • 19. Acute Hepatic Porphyrias: "Purple Flags"-Clinical Features That Should Prompt Specific Diagnostic Testing.
    Anderson KE, Desnick RJ, Stewart MF, Ventura P, Bonkovsky HL.
    Am J Med Sci; 2022 Jan 04; 363(1):1-10. PubMed ID: 34606756
    [Abstract] [Full Text] [Related]

  • 20. Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals.
    Lissing M, Vassiliou D, Floderus Y, Harper P, Bottai M, Kotopouli M, Hagström H, Sardh E, Wahlin S.
    J Intern Med; 2022 Jun 04; 291(6):824-836. PubMed ID: 35112415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.